MSI2 and acute myeloid leukemia: Both MSI2 (RNA‐binding protein Musashi‐2) and DNMT3B (DNA Methyltransferase 3 Beta) have been investigated in AML independently,43, 48, 50 and higher expression of both RBPs are associated with poorer survival.